NeoGenomics, Inc. Deferred Tax Assets, Operating Loss Carryforwards
NeoGenomics, Inc. (NEO) had Deferred Tax Assets, Operating Loss Carryforwards of $116.02 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOperatingLossCarryforwards · last filed 2026-02-17
- 2025-12-31: Deferred Tax Assets, Operating Loss Carryforwards $116.02M.
- 2024-12-31: Deferred Tax Assets, Operating Loss Carryforwards $110.89M.
- 2023-12-31: Deferred Tax Assets, Operating Loss Carryforwards $114.86M.
- 2022-12-31: Deferred Tax Assets, Operating Loss Carryforwards $106.74M.
| Period end | Deferred Tax Assets, Operating Loss Carryforwards |
|---|---|
| 2025-12-31 | $116.02M 10-K · filed 2026-02-17 |
| 2024-12-31 | $110.89M 10-K · filed 2026-02-17 |
| 2023-12-31 | $114.86M 10-K · filed 2025-02-18 |
| 2022-12-31 | $106.74M 10-K · filed 2024-02-20 |
| 2021-12-31 | $81.90M 10-K · filed 2023-02-24 |
| 2020-12-31 | $33.89M 10-K · filed 2022-02-25 |
| 2019-12-31 | $17.69M 10-K · filed 2021-02-25 |
| 2018-12-31 | $17.82M 10-K · filed 2020-02-28 |
| 2017-12-31 | $12.28M 10-K · filed 2019-02-26 |
| 2016-12-31 | $12.22M 10-K · filed 2018-03-13 |
| 2015-12-31 | $502.00K 10-K · filed 2017-03-14 |
| 2012-12-31 | $2.75M 10-K · filed 2013-02-21 |
| 2011-12-31 | $3.30M 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |